Rule 15c2-11 is the SEC rule governing the publication of quotations for OTC securities. In its revised form, effective September 27, 2021, it requires broker-dealers to review and maintain current issuer information before publishing quotations for any covered OTC security. The 2021 revision substantially strengthened the rule's information requirements and narrowed its piggyback exception.
The revision generated uncertainty in one specific area: whether Rule 15c2-11 applies to quotations for fixed income securities, including corporate bonds, municipal bonds, and other debt instruments that trade in the OTC market. Fixed income dealers and broker-dealers with combined OTC equity and fixed income activities had compliance questions about whether their fixed income quotation activities required Rule 15c2-11 reviews.
In July 2026, the SEC's Division of Trading and Markets issued staff guidance specifically clarifying that Rule 15c2-11 applies only to equity securities trading in the OTC market. Fixed income securities are not within the rule's scope.
This post covers what Rule 15c2-11 requires, why the fixed income question arose, what the July 2026 staff guidance confirms, what the equity/fixed income boundary means in practice, and what corporate issuers with publicly traded debt need to understand about the rule's non-application to their bonds.
What Is SEC Rule 15c2-11 and What Does It Require for OTC Equity Quotations?
Rule 15c2-11 under the Securities Exchange Act of 1934 governs the publication of quotations in the OTC market. Originally adopted in 1971 to address fraud in thinly-traded OTC equity securities, it was substantially revised effective September 27, 2021 to require broker-dealers to review and confirm that current issuer information is publicly available before publishing quotations for any covered OTC security.
Under the revised rule, before a broker-dealer publishes or submits a quotation for an OTC security in a quotation medium, it must have a reasonable basis to believe that specified current issuer information is publicly available. That information includes: the issuer's most recent annual report, most recent quarterly or semi-annual report, current financial statements, a description of the issuer's business and securities, and information about management and financial condition.
The information must be publicly accessible through OTC Markets Group's data service or through EDGAR. For reporting companies (those filing with the SEC under Section 13 or 15(d)), the EDGAR filing satisfies the rule's information requirements and a safe harbour applies. The rule creates its greatest compliance burden for non-reporting OTC equity issuers, which must affirmatively publish the required current information to permit quotations.
The rule includes a piggyback exception allowing broker-dealers to publish quotations without their own full review if a qualified broker-dealer is already quoting the security and other conditions are met. The 2021 revision narrowed this exception to prevent perpetual quotation of dormant or inactive securities.
[Visual suggestion 1: Rule 15c2-11 compliance decision tree for OTC securities] Place here. A decision tree. Question 1: Is the security an OTC equity security? If no (debt security, bond): July 2026 staff guidance confirms Rule 15c2-11 does not apply; follow FINRA Rule 5250 and applicable FINRA/MSRB framework instead. If yes (OTC equity): proceed to Question 2. Question 2: Is the issuer a reporting company on EDGAR? If yes: safe harbour applies, proceed with quotation. If no: review for current issuer information publicly available. Question 3: Is the piggyback exception available? If yes: may rely on qualified broker-dealer's quotation without full review. If no: conduct own review before publishing quotation. This is the compliance flowchart a broker-dealer OTC compliance officer uses when evaluating Rule 15c2-11 applicability for new securities.
Why Did the Fixed Income Question Arise Under Rule 15c2-11?
The 2021 revision was directed at OTC equity market fraud and manipulation. The SEC's adopting release and press materials described the rule's purpose in terms of OTC equity securities. However, the rule's text uses the term "OTC security," which is not defined to exclude debt instruments. The Exchange Act's broader definition of "security" includes both equity and debt.
Fixed income dealers had specific compliance concerns. Rule 15c2-11's information requirements, enumerated for equity securities, do not map cleanly onto fixed income disclosure structures. Corporate bonds, municipal bonds, and asset-backed securities have different disclosure regimes than OTC equity issuers. The issuer information requirements calibrated for pink sheet equities do not have obvious fixed income equivalents.
FINRA rules (Rule 5250 for quotations, Rule 5310 for best execution, Rule 6730 for TRACE reporting) provide the primary regulatory framework for OTC fixed income. Broker-dealers active in both OTC equity and fixed income had compliance questions about whether a parallel Rule 15c2-11 programme was required for fixed income.
The International Capital Market Association, SIFMA, and other market participants had advocated for explicit SEC staff confirmation that fixed income is outside Rule 15c2-11's scope. The July 2026 guidance provides that confirmation.
What Did the SEC Division of Trading and Markets Confirm in July 2026?
The SEC Division of Trading and Markets issued staff guidance in July 2026 confirming that Rule 15c2-11 applies only to OTC equity securities and not to fixed income securities, including corporate bonds, municipal bonds, government securities, mortgage-backed securities, and other debt instruments trading in the OTC market.
The guidance addresses the concern that "OTC security" in the rule's text could be read to include debt instruments. The staff's position: the rule was designed for the OTC equity market, its requirements are calibrated to equity securities, and it does not apply to fixed income quotation activities.
Three specific implications confirmed by the guidance:
Broker-dealers publishing quotations for corporate bonds, municipal bonds, or other fixed income instruments in the OTC market are not subject to Rule 15c2-11's information review requirements for those quotations.
The separate regulatory frameworks governing fixed income OTC quotations (primarily FINRA rules and MSRB rules) continue to apply and are unchanged.
Broker-dealers with both OTC equity and fixed income activities must maintain Rule 15c2-11 programmes for OTC equity but are not required to extend them to fixed income.
The guidance is a Division of Trading and Markets staff position, not a formal rule amendment or Commission-level interpretive release. It does not have the force of law but represents the staff's current interpretive position and provides a reliable basis for compliance planning.
What Does "OTC Equity Security" Mean and How Is the Boundary Drawn?
OTC equity securities within Rule 15c2-11's scope are equity securities not listed on a national securities exchange (NYSE, Nasdaq, NYSE American) that trade in the OTC market. They include pink sheet securities, grey market securities, OTCQX and OTCQB securities, and shares of reporting companies that have chosen not to list on a national exchange.
Fixed income securities outside Rule 15c2-11's scope include corporate bonds (investment grade and high yield, whether registered or Rule 144A), municipal bonds, US government and agency securities, mortgage-backed and asset-backed securities.
The boundary is drawn at the equity/debt distinction, not at the exchange-listed/OTC distinction. An equity security trading OTC is within Rule 15c2-11's scope. A debt security trading OTC is outside its scope regardless of whether the issuer is a reporting company.
The Rule 144A market context: many corporate bond issuances are completed under Rule 144A for Qualified Institutional Buyers and subsequently registered for public resale. Both the 144A bonds and the registered bonds trade in the TRACE-reported OTC market. Per the July 2026 guidance, neither is subject to Rule 15c2-11.
What Does This Mean for Fixed Income Dealers and Broker-Dealers With Combined OTC Activities?
For pure fixed income dealers: Rule 15c2-11 compliance programmes are not required for fixed income quotation activities. FINRA Rules 5250, 5310, and 6730, and applicable MSRB rules, provide the regulatory framework.
For broker-dealers with both OTC equity and fixed income activities: compliance system differentiation is the key operational implication. Rule 15c2-11 reviews apply to OTC equity quotations and must be segregated from fixed income quotation compliance processes. Compliance systems that have been applying Rule 15c2-11 reviews to fixed income quotations on an abundance-of-caution basis should be updated to limit those reviews to OTC equity securities.
Written supervisory procedures should be updated to reflect the July 2026 guidance explicitly: Rule 15c2-11 applies to OTC equity securities, fixed income quotations are governed by FINRA and MSRB rules. The instrument-type classification (equity vs. fixed income) in the firm's compliance surveillance system is the operative distinction.
What Do Corporate Issuers With Publicly Traded Debt Need to Know About the Rule's Non-Application?
For reporting corporate issuers (filing Form 10-K, 10-Q, 8-K with the SEC): the July 2026 guidance confirms that Rule 15c2-11 does not apply to their bonds' OTC trading. The broker-dealers making markets in the company's bonds are not subject to Rule 15c2-11 obligations for those activities. The company's primary SEC disclosure obligations remain unchanged: Form 10-K, 10-Q, 8-K, and other periodic reports.
For non-reporting corporate issuers with bonds trading OTC under Rule 144A or Regulation D: Rule 15c2-11 similarly does not apply. The applicable regulatory frameworks for the broker-dealers quoting those bonds are FINRA-governed rather than Rule 15c2-11-governed.
The practical bottom line: no corporate issuer, reporting or non-reporting, has any additional compliance obligation with respect to Rule 15c2-11 arising from its bonds' OTC trading. The rule has always been aimed at OTC equity quotation activity, and the July 2026 guidance explicitly confirms that scope.
How Does Rule 15c2-11 Interact With FINRA TRACE and Other Fixed Income Reporting Requirements?
The July 2026 guidance clarifies what does not apply to fixed income, but it is equally important to understand what does apply.
FINRA Rule 6730 governs TRACE reporting for corporate bonds, agency debt, and certain other fixed income securities. Broker-dealers effecting transactions in TRACE-eligible securities must report those transactions to FINRA. TRACE reporting is not affected by the Rule 15c2-11 clarification.
FINRA Rule 5250 governs quotations for fixed income securities, with its own information and standards requirements. FINRA Rule 5310 governs best execution for fixed income transactions. MSRB Rule G-13 governs quotations for municipal securities.
These rules provide the complete regulatory framework for OTC fixed income quotations and continue to apply without change.
[Visual suggestion 2: OTC equity vs OTC fixed income regulatory framework comparison] Place here. A two-column table. Left column (OTC Equity): Primary quotation rule is Rule 15c2-11, information requirements are current issuer information per 15c2-11 before quotation, post-trade reporting is through FINRA OTC Reporting Facility. Right column (OTC Fixed Income): Primary quotation rule is FINRA Rule 5250 (not Rule 15c2-11), post-trade reporting is TRACE per FINRA Rule 6730, best execution is governed by FINRA Rule 5310, municipal securities also governed by MSRB Rule G-13. This is the compliance reference table a broker-dealer distributes to trading supervisors when updating WSPs after the July 2026 guidance.
What Should Broker-Dealers and Compliance Officers Do Now?
Four specific actions following the July 2026 guidance.
Update written supervisory procedures: revise WSPs to confirm explicitly that Rule 15c2-11 applies to OTC equity securities and does not apply to fixed income securities, citing the July 2026 Division of Trading and Markets guidance.
Reconfigure compliance surveillance systems: update any system that applies Rule 15c2-11 reviews to fixed income quotations to limit those reviews to OTC equity securities. Confirm that instrument-type classification correctly routes each security type to its applicable regulatory framework.
Assess historical compliance work: broker-dealers that conducted Rule 15c2-11 reviews for fixed income on an abundance-of-caution basis need not remediate that work. The guidance provides clarity for prospective compliance.
Distribute and train: share the July 2026 guidance with OTC trading supervisors and compliance staff. Include it in regular compliance training. Fixed income trading supervisors should understand that their quotation activities are governed by FINRA and MSRB rules, not Rule 15c2-11.
Frequently Asked Questions
Does Rule 15c2-11 apply to corporate bond quotations?
No. The SEC Division of Trading and Markets confirmed in July 2026 that Rule 15c2-11 applies only to OTC equity securities. Corporate bonds and other fixed income instruments trading in the OTC market are not within the rule's scope. Applicable regulatory frameworks for fixed income quotations are FINRA Rule 5250, FINRA Rule 5310, and FINRA Rule 6730 for TRACE reporting.
What is Rule 15c2-11 and what did the 2021 revision change?
Rule 15c2-11 requires broker-dealers to review and confirm that current issuer information is publicly available before publishing quotations for OTC equity securities. The 2021 revision (effective September 27, 2021) strengthened these requirements by narrowing the piggyback exception, requiring information to be available through EDGAR or OTC Markets Group, and expanding the rule's reach over dormant securities.
Do reporting companies need to take any action for their OTC-traded bonds after this guidance?
No. The July 2026 guidance confirms that Rule 15c2-11 does not apply to debt securities. Corporate issuers with bonds trading in the OTC market have no new obligations. Their primary SEC disclosure obligations (Form 10-K, 10-Q, 8-K) are unchanged.
What regulatory framework applies to OTC corporate bond quotations?
FINRA Rule 5250 governs quotations for fixed income securities. FINRA Rule 5310 governs best execution. FINRA Rule 6730 governs TRACE post-trade reporting. For municipal securities, MSRB Rule G-13 applies. These frameworks are unchanged by the Rule 15c2-11 clarification.
Is municipal bond trading subject to Rule 15c2-11?
No. Municipal securities are fixed income instruments and are not within Rule 15c2-11's scope per the July 2026 guidance. Municipal securities dealers are governed by MSRB Rule G-13 and other applicable MSRB rules for their quotation activities.
Key Takeaways
- In July 2026, the SEC Division of Trading and Markets confirmed that Rule 15c2-11 applies only to OTC equity securities and does not apply to fixed income securities including corporate bonds, municipal bonds, mortgage-backed securities, and other debt instruments.
- The guidance resolves a compliance uncertainty arising from the 2021 Rule 15c2-11 revision, under which some broker-dealers questioned whether the rule's information requirements extended to fixed income OTC quotation activities.
- For pure fixed income dealers: Rule 15c2-11 compliance programmes are not required. Applicable frameworks are FINRA Rules 5250, 5310, and 6730, and MSRB rules for municipal securities.
- For broker-dealers with combined OTC equity and fixed income activities: Rule 15c2-11 reviews apply to OTC equity quotations only. Compliance systems must route fixed income quotations to applicable FINRA frameworks rather than to Rule 15c2-11.
- For corporate issuers with OTC-traded bonds: no new compliance obligations. The rule has never applied to debt securities and the guidance confirms this. SEC periodic reporting obligations and TRACE reporting by broker-dealers are unchanged.
- Compliance actions: update written supervisory procedures, reconfigure surveillance systems to exclude fixed income from Rule 15c2-11 reviews, and distribute the guidance to OTC trading and compliance staff.
